Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart

This publication has 53 references indexed in Scilit:

• Specific enhancement of sarcomeric response to Ca²⁺protects murine myocardium against ischemia-reperfusion dysfunction
  American Journal of Physiology-Heart and Circulatory Physiology, 2005
• Protection against endotoxemia‐induced contractile dysfunction in mice with cardiac‐specific expression of slow skeletal troponin I
  The FASEB Journal, 2005
• Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation
  American Journal of Physiology-Heart and Circulatory Physiology, 2004
• Advances in positive inotropic therapy: Levosimendan *
  Critical Care Medicine, 2003
• Single Mutation (A162H) in Human Cardiac Troponin I Corrects Acid pH Sensitivity of Ca2+-regulated Actomyosin S1 ATPase
  Published by Elsevier ,2002
• Vasodilation and Mechanoenergetic Inefficiency Dominates the Effect of the "Ca 2+ -sensitizer" MCI-154 in Intact Pigs
  Scandinavian Cardiovascular Journal, 2002
• Calcium-Induced Structural Transition in the Regulatory Domain of Human Cardiac Troponin C^,
  Biochemistry, 1997
• Interaction of Cardiotonic Thiadiazinone Derivatives with Cardiac Troponin C
  Published by Elsevier ,1996
• Pimobendan directly sensitizes reconstituted thin filament to slide on cardiac myosin
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Hemodynamic, Neurohumoral, and Myocardial Energetic Effects of Pimobendan, a Novel Calcium-Sensitizing Compound, in Patients with Mild to Moderate Heart Failure
  Journal of Cardiovascular Pharmacology, 1994